% Requires: \usepackage{booktabs}
\newgeometry{left=1.4cm, right=1.4cm, top=2.2cm, bottom=2.2cm}
\begin{landscape}
    \begin{table}[ht]
        \centering
        \small
        \caption{Key characteristics on the 12 prognostic model developments, ordered by outcome and year published. Each row corresponds to a different model developed by the referenced study. -: not reported; +ve: positive; Cand: candidate; clin: clinical; EPP: events per predictor parameter; HIV: human immunodeficiency virus; lab: laboratory; y: years}
        \label{tab:sr-key-characteristics}
        \begin{threeparttable}
            \begin{tabularx}{\linewidth}{@{} X l l l c c l l l @{}}
                \toprule
                \textbf{Study}                                                                   & \textbf{Model}         & \textbf{Data source} & \textbf{Location}                & \textbf{\% Male} & \textbf{\% HIV} & \textbf{Events}\tnote{1} & \textbf{Predictors}\tnote{2} & \textbf{EPP}\tnote{2} \\
                                                                                                 & \textbf{described}     &                      & Period                           &                  & \textbf{+ve}    & Sample size (\%)         & \textbf{Final}, Cand.        &                       \\
                \midrule
                \rowcolor{rowyellow}\multicolumn{9}{@{}l@{}}{\textbf{Outcome: Registry-reported mortality}}                                                                                                                                                                                                \\
                \midrule
                \textbf{de Araújo}                                                               & -                      & Registry             & \textbf{Brazil (Belo Horizonte)} & -                & -               & \textbf{49}              & \textbf{4}, 48               & 1.0                   \\
                \textbf{2012}\cite{dearaujoEarlyClinicalManifestations2012}                      &                        &                      & 2007--09                         &                  &                 & 376 (13.0)               &                              &                       \\
                \rowcolor{rowgrey}\textbf{Coura-Vital}                                           & -                      & Registry             & \textbf{Brazil (Nationwide)}     & 61.7             & 7.0             & \textbf{770}             & \textbf{12}, (29)            & (26.6)                \\
                \rowcolor{rowgrey}\textbf{2014}\cite{coura-vitalPrognosticFactorsScoring2014}    &                        &                      & 2007--11                         &                  &                 & 12,333 (6.2)             &                              &                       \\
                \midrule
                \rowcolor{rowyellow}\multicolumn{9}{@{}l@{}}{\textbf{Outcome: In-hospital mortality}}                                                                                                                                                                                                      \\
                \midrule
                \textbf{Werneck}                                                                 & -                      & Case-control         & \textbf{Brazil (Teresina) }      & 68.9             & -               & \textbf{12}              & \textbf{4}, (15)             & (0.8)                 \\
                \textbf{2003}\cite{werneckPrognosticFactorsDeath2003}                            &                        &                      & - ($<$ 2003)                     &                  &                 & 90 (13.3)                &                              &                       \\
                \rowcolor{rowgrey}\textbf{Sampaio}                                               & -                      & Retrospective        & \textbf{Brazil (Recife) }        & 50.4             & -               & \textbf{57}              & \textbf{6}, (15)             & (3.8)                 \\
                \rowcolor{rowgrey}\textbf{2010}\cite{sampaioRiskFactorsDeath2010}                &                        &                      & 1996--2006                       &                  &                 & 546 (10.4)               &                              &                       \\
                \textbf{Costa}                                                                   & $<$ 2 y, clin only     & Prospective          & \textbf{Brazil (Teresina) }      & -                & -               & \textbf{-}               & \textbf{6}, (25)             & (0.9)                 \\
                \textbf{2016}\cite{costaPredictingDeathKalaazar2016}\tnote{3}                    &                        &                      & 2005--08                         &                  &                 & 314 (-)                  &                              &                       \\
                \rowcolor{rowgrey}                                                               & $<$ 2 y, clin + lab    & Prospective          & \textbf{Brazil (Teresina)}       & -                & -               & \textbf{-}               & \textbf{6}, (31)             & (0.7)                 \\
                \rowcolor{rowgrey}                                                               &                        &                      & 2005--08                         &                  &                 & 291 (-)                  &                              &                       \\
                                                                                                 & $\geq$ 2 y, clin only  & Prospective          & \textbf{Brazil (Teresina)}       & -                & -               & \textbf{-}               & \textbf{9}, (27)             & (1.6)                 \\
                                                                                                 &                        &                      & 2005--08                         &                  &                 & 569 (-)                  &                              &                       \\
                \rowcolor{rowgrey}                                                               & $\geq$ 2 y, clin + lab & Prospective          & \textbf{Brazil (Teresina)}       & -                & -               & \textbf{-}               & \textbf{9}, (33)             & (1.2)                 \\
                \rowcolor{rowgrey}                                                               &                        &                      & 2005--08                         &                  &                 & 538 (-)                  &                              &                       \\
                \textbf{Abongomera}                                                              & -                      & Retrospective        & \textbf{Ethiopia (Abdurafi)}     & 95.9             & 19.3            & \textbf{99}              & \textbf{8}, 16               & 6.2                   \\
                \textbf{2017}\cite{abongomeraDevelopmentExternalValidation2017}                  &                        &                      & 2008--13                         &                  &                 & 1,686 (5.9)              &                              &                       \\
                \rowcolor{rowgrey}\textbf{Kämink}                                                & $<$ 19 y               & Retrospective        & \textbf{South Sudan (Lankien)}   & 54.2             & excl.           & \textbf{116}             & \textbf{8}, 20               & 5.8                   \\
                \rowcolor{rowgrey}\textbf{2017}\cite{kaminkClinicalSeverityScoring2017}          &                        &                      & 2013--15                         &                  &                 & 4,931 (2.4)              &                              &                       \\
                                                                                                 & $\geq$ 19 y            & Retrospective        & \textbf{South Sudan (Lankien)}   & 56.2             & excl.           & \textbf{70}              & \textbf{8}, 21               & 3.3                   \\
                                                                                                 &                        &                      & 2013--15                         &                  &                 & 1,702 (4.1)              &                              &                       \\
                \rowcolor{rowgrey}\textbf{Foinquinos}                                            & Sampaio updating       & Retrospective        & \textbf{Brazil (Recife)}         & 48.7             & -               & \textbf{10}              & \textbf{1}, 1                & 10.0                  \\
                \rowcolor{rowgrey}\textbf{2021}\cite{foinquinosTemporalValidationPredictive2021} &                        &                      & 2008--18                         &                  &                 & 156 (6.4)\tnote{4}       &                              &                       \\
                \bottomrule
            \end{tabularx}
            \begin{tablenotes}
                \footnotesize
                \item[1] Including patients with missing predictor information and excluding patients with missing outcomes.
                \item[2] Figures presented in brackets are estimated from incomplete reporting.
                \item[3] Total events in combined development dataset reported as 7.5\% (66/883) and not disaggregated by age group. EPP is calculated based on extrapolating the 7.5\% event rate to each model development dataset.
                \item[4] Sample size excludes both participants with missing predictors and missing/excluded outcomes.
            \end{tablenotes}
        \end{threeparttable}
    \end{table}
\end{landscape}
\restoregeometry
